QCM
VRTX icon

QRG Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

QRG Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
21,665
+1,765
+9% +$782K 0.09% 193
2026
Q1 		$8.89M Buy
19,900
+1,504
+8% +$701K 0.09% 190
2025
Q4 		$8.34M Buy
18,396
+2,563
+16% +$1.1M 0.09% 184
2025
Q3 		$6.2M Sell
15,833
-3,203
-17% -$1.34M 0.08% 214
2025
Q2 		$8.47M Buy
19,036
+1,643
+9% +$757K 0.07% 229
2025
Q1 		$8.43M Buy
17,393
+831
+5% +$387K 0.09% 219
2024
Q4 		$6.67M Sell
16,562
-1,780
-10% -$825K 0.07% 240
2024
Q3 		$8.53M Sell
18,342
-1,550
-8% -$745K 0.09% 197
2024
Q2 		$9.32M Buy
19,892
+5,703
+40% +$2.48M 0.11% 179
2024
Q1 		$5.93M Buy
14,189
+543
+4% +$230K 0.08% 233
2023
Q4 		$5.55M Buy
13,646
+1,493
+12% +$552K 0.08% 240
2023
Q3 		$4.23M Buy
+12,153
New +$4.25M 0.07% 256

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

QRG Capital Management's VRTX Position: Q2 2026 in Review

QRG Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 8.9% in Q2 2026, buying an estimated $782K and bringing the position to 21,665 shares worth $10.8M. The position accounts for 0.09% of the portfolio, ranked #193.

QRG Capital Management first reported a position in VRTX in Q3 2023 and has held it in 12 quarters since. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • QRG Capital Management held 21,665 shares of Vertex Pharmaceuticals worth $10.8M as of Q2 2026.
  • QRG Capital Management bought 1,765 Vertex Pharmaceuticals shares in Q2 2026, an estimated $782K.
  • Vertex Pharmaceuticals made up 0.09% of QRG Capital Management's portfolio in Q2 2026, its #193 holding.
  • QRG Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.